PCPC Reaffirms Commitment To FDA Negotiations On Regulatory Overhaul
This article was originally published in The Rose Sheet
Executive Summary
A tentative framework for modernizing cosmetics regulation was agreed upon by FDA and industry reps in July, but the agency has since questioned industry’s commitment, giving rise to media reports suggesting that the effort has failed. PCPC says its members remain invested in the process and look forward to ironing out the specifics.